Type Public Industry Biotechnology Headquarters Beijing, China Subsidiaries Xia Jin Plasma Co | Traded as NASDAQ: CBPO Website www.chinabiologic.com Founded 1989 | |
 | ||
Stock price CBPO (NASDAQ) US$ 100.32 +0.33 (+0.33%)3 Mar, 4:00 PM GMT-5 - Disclaimer | ||
China Biologic Products, Inc., through its indirect majority-owned subsidiary Shandong Taibang, is the only blood plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province in China with a population of 93 million. The company is engaged in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Plasma-based human albumin is used mainly to increase blood volume while Immunoglobulin is used for disease prevention and treatment.
References
China Biologic Products, Inc. Wikipedia(Text) CC BY-SA